Literature DB >> 11142176

Screening and early diagnosis of dementia.

N Relkin.   

Abstract

In current practice, the diagnosis of Alzheimer's disease is often delayed for several years after the initial onset of symptoms. Earlier diagnosis is desirable for several reasons. It allows the patient, family, and clinician to plan more effectively for the future, reduces the likelihood of catastrophic events such as motor vehicle accidents, and permits more effective administration of medications to delay symptom progression. Early detection of dementia can improve the quality of life for the patient and the caregiver and ultimately reduce total care expenditures by delaying the time to nursing home admission and other costly outcomes.

Entities:  

Mesh:

Year:  2000        PMID: 11142176

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  9 in total

Review 1.  Barriers to implementation of case management for patients with dementia: a systematic mixed studies review.

Authors:  Vladimir Khanassov; Isabelle Vedel; Pierre Pluye
Journal:  Ann Fam Med       Date:  2014 Sep-Oct       Impact factor: 5.166

2.  Characterising Australian memory clinics: current practice and service needs informing national service guidelines.

Authors:  Sharon L Naismith; Johannes C Michaelian; Lee-Fay Low; Valerie Arsenova; Inga Mehrani; Katrina Fyfe; Nicole A Kochan; Susan E Kurrle; Christopher Rowe; Perminder S Sachdev
Journal:  BMC Geriatr       Date:  2022-07-14       Impact factor: 4.070

3.  Validity and reliability of the Brain Health Self-Efficacy Scale for the elderly.

Authors:  Yining Gao; Ming Cui; Chunyan Yang; Yuejing Wu; Yun Long; Yaopian Chen; Hongshen Liu; Lin Sun; Yinghua Yang; Xia Li
Journal:  Gen Psychiatr       Date:  2020-07-28

Review 4.  Rapid appraisal of barriers to the diagnosis and management of patients with dementia in primary care: a systematic review.

Authors:  Tamar Koch; Steve Iliffe
Journal:  BMC Fam Pract       Date:  2010-07-01       Impact factor: 2.497

5.  "Making Sense of a Disease That Makes No Sense": Understanding Alzheimer's Disease and Related Disorders Among Caregivers and Providers Within Alaska Native Communities.

Authors:  Jordan P Lewis; Spero M Manson; Valarie B Jernigan; Carolyn Noonan
Journal:  Gerontologist       Date:  2021-04-03

Review 6.  2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.

Authors:  A Leuzy; N J Ashton; N Mattsson-Carlgren; A Dodich; M Boccardi; J Corre; A Drzezga; A Nordberg; R Ossenkoppele; H Zetterberg; K Blennow; G B Frisoni; V Garibotto; O Hansson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-05       Impact factor: 9.236

7.  Rates of formal diagnosis of dementia in primary care: The effect of screening.

Authors:  Tilly Eichler; Jochen René Thyrian; Johannes Hertel; Bernhard Michalowsky; Diana Wucherer; Adina Dreier; Ingo Kilimann; Stefan Teipel; Wolfgang Hoffmann
Journal:  Alzheimers Dement (Amst)       Date:  2015-03-29

8.  Assessing the Penetrance of Dementia Services.

Authors:  Michael Rozsa; Leon Flicker
Journal:  Healthcare (Basel)       Date:  2019-06-27

9.  Combining olfaction and cognition measures to screen for mild cognitive impairment.

Authors:  Mary Ann F Kirkpatrick; Wendell Combest; Marian Newton; Yvonne Teske; John Cavendish; Rhonda McGee; Danielle Przychodzin
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.